Exane Derivatives’s Thomson Reuters TRI Stock Holding History

Exane Derivatives’s Portfolio TRI Stock Details TRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-131	Closed	-$8.9K	–	695
2019 Q2	$8.9K	Hold	131	–	–	﹤0.01%	462
2019 Q1	$8.17K	Hold	131	–	–	﹤0.01%	400
2018 Q4	$6.67K	Buy	131 +12	+10%	+$643	﹤0.01%	487
2018 Q3	$6.32K	Hold	119	–	–	﹤0.01%	455
2018 Q2	$5.53K	Hold	119	–	–	﹤0.01%	470
2018 Q1	$5.31K	Hold	119	–	–	﹤0.01%	432
2017 Q4	$6.03K	Hold	119	–	–	﹤0.01%	420
2017 Q3	$6.35K	Hold	119	–	–	﹤0.01%	420
2017 Q2	$6.39K	Hold	119	–	–	﹤0.01%	425
2017 Q1	$5.99K	Hold	119	–	–	﹤0.01%	369
2016 Q4	$6.02K	Hold	119	–	–	﹤0.01%	426
2016 Q3	$5.69K	Hold	119	–	–	﹤0.01%	437
2016 Q2	$5.57K	Hold	119	–	–	﹤0.01%	390
2016 Q1	$5.61K	Hold	119	–	–	﹤0.01%	440
2015 Q4	$5.21K	Hold	119	–	–	﹤0.01%	361
2015 Q3	$5.42K	Hold	119	–	–	﹤0.01%	377
2015 Q2	$5.31K	Hold	119	–	–	﹤0.01%	393
2015 Q1	$5.49K	Hold	119	–	–	﹤0.01%	403
2014 Q4	$5.58K	Buy	+119	New	+$5.27K	﹤0.01%	432

Other funds holding TRI

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exane Derivatives's TRI Position: Q3 2019 in Review

Exane Derivatives sold out of Thomson Reuters (TRI) in Q3 2019, closing a stake of 131 shares — an estimated $8.9K sold.

Exane Derivatives first reported a position in TRI in Q4 2014 and held it in 19 quarters. The position peaked at $8.9K in Q2 2019. 312 funds tracked by Wall St. Rank hold TRI as of Q3 2019.

Exane Derivatives reported no remaining Thomson Reuters position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 131 Thomson Reuters shares in Q3 2019, an estimated $8.9K.
Exane Derivatives first reported a position in Thomson Reuters in Q4 2014 and held it in 19 quarters.
Exane Derivatives's Thomson Reuters position peaked at $8.9K in Q2 2019.
312 funds tracked by Wall St. Rank held Thomson Reuters as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.